Literature DB >> 1333051

Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids.

A Schmidt1, N Endo, S J Rutledge, R Vogel, D Shinar, G A Rodan.   

Abstract

We have identified a novel member of the steroid hormone receptor superfamily by cDNA cloning from a human osteosarcoma SAOS-2/B10 cell library. Sequence analysis predicts a protein of 441 amino acids, which includes the conserved amino acid residues characteristic of the DNA- and ligand-binding domains of nuclear receptors. Amino acid sequence alignment and transcriptional activation experiments revealed that the new protein is closely related to the mouse peroxisome proliferator activated receptor. The overall homology is 62%, and the highest similarity is seen in the DNA- and ligand-binding domains, 86% and 71%, respectively. Northern blot analysis showed that in mature rats, the receptor is highly expressed in heart, kidney, and lung as a transcript of approximately 3500 nucleotides. In human cells, the size of the mRNA is approximately 4000 nucleotides. Transcription assays using hybrid receptors consisting of the ligand-binding domain of the new protein and the DNA-binding domain of the glucocorticoid receptor showed weak stimulation by the peroxisome proliferator activator WY14643, suggesting a relationship to that receptor. Similar stimulation was observed with arachidonic and oleic acid (100-250 microM).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333051     DOI: 10.1210/mend.6.10.1333051

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  80 in total

1.  Playing "telephone": bioactive lipids as mediators of intercompartmental communication in the alveolus.

Authors:  M Peters-Golden
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma.

Authors:  Priyadarshini Raman; Barbara L F Kaplan; Jerry T Thompson; John P Vanden Heuvel; Norbert E Kaminski
Journal:  Mol Pharmacol       Date:  2011-04-21       Impact factor: 4.436

Review 3.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

4.  Pathophysiological role of enhanced bone marrow adipogenesis in diabetic complications.

Authors:  Meghan A Piccinin; Zia A Khan
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

5.  Identification of fatty acid methyl ester as naturally occurring transcriptional regulators of the members of the peroxisome proliferator-activated receptor family.

Authors:  A Schmidt; R L Vogel; K M Witherup; S J Rutledge; S M Pitzenberger; M Adam; G A Rodan
Journal:  Lipids       Date:  1996-11       Impact factor: 1.880

6.  Molecular basis of differentiation therapy for soft tissue sarcomas.

Authors:  Gaurav Luther; Richard Rames; Eric R Wagner; Gaohui Zhu; Qing Luo; Yang Bi; Stephanie H Kim; Jian-Li Gao; Enyi Huang; Ke Yang; Linyuan Wang; Xing Liu; Mi Li; Ning Hu; Yuxi Su; Xiaoji Luo; Liang Chen; Jinyong Luo; Rex C Haydon; Hue H Luu; Lan Zhou; Tong-Chuan He
Journal:  Trends Cancer Res       Date:  2010

7.  Therapeutic Implications of PPARgamma in Human Osteosarcoma.

Authors:  Eric R Wagner; Bai-Cheng He; Liang Chen; Guo-Wei Zuo; Wenli Zhang; Qiong Shi; Qing Luo; Xiaoji Luo; Bo Liu; Jinyong Luo; Farbod Rastegar; Connie J He; Yawen Hu; Barrett Boody; Hue H Luu; Tong-Chuan He; Zhong-Liang Deng; Rex C Haydon
Journal:  PPAR Res       Date:  2010-02-16       Impact factor: 4.964

8.  Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.

Authors:  A Vidal-Puig; M Jimenez-Liñan; B B Lowell; A Hamann; E Hu; B Spiegelman; J S Flier; D E Moller
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

9.  15-deoxy-Delta 12,14-ProstaglandinJ2 regulates dedifferentiation through peroxisome proliferator-activated receptor-gamma-dependent pathway but not COX-2 expression in articular chondrocytes.

Authors:  Ji-Hye Lee; Seon-Mi Yu; Eun-Kyung Yoon; Won-Kil Lee; Jae-Chang Jung; Song-Ja Kim
Journal:  J Korean Med Sci       Date:  2007-10       Impact factor: 2.153

10.  Ligand modulated antagonism of PPARgamma by genomic and non-genomic actions of PPARdelta.

Authors:  Mattias C U Gustafsson; Deborah Knight; Colin N A Palmer
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.